Alkylating Agents, Newly Diagnosed Multiple Myeloma (NDMM), No Cyclophosphamide+Bortezomib+Dexamethasone (NO CVD), Cyclophosphamide+Bortezomib+Dexamethasone (CVD), Phase 3
### Instruction:
Identify the study with the following condition. 
### Input:
Alkylating Agents, Newly Diagnosed Multiple Myeloma (NDMM), No Cyclophosphamide+Bortezomib+Dexamethasone (NO CVD), Cyclophosphamide+Bortezomib+Dexamethasone (CVD), Phase 3 
### Output:
Popular Name is Myeloma XI, Study ID is NCT01554852